JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description:ML-385 is a novel, potent and selective NRF2 inhibitor (Nrf2: nuclear factor E2 related factor 2) with an IC50 of 1.9 uM. ML385 interacts with NRF2 and affects the DNA binding activity of the NRF2-MAFG protein complex. The addition of ML385 decreases anisotropy dose-dependently. ML-385 selectively intervenes therapeutic resistance in KEAP1-Deficient NSCLC Tumors. It acts by inhibiting the downstream target gene expression of NRF2. ML385 in combination with chemotherapeutic agents such as carboplatin showed significant tumor-suppression activity.
References: ACS Chem Biol. 2016 Nov 18; 11(11):3214-3225. Epub 2016 Oct 17.
ML385; ML 385; ML-385
Exact Mass: 511.1566
Chemical Name: N-[4-[2, 3-dihydro-1-(2-methylbenzoyl)-1H-indol-5-yl]-5-methyl-2-thiazolyl]-1, 3-benzodioxole-5-acetamide
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!